Fortress Biotech Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.41

+0.11 (+4.78%)

As of May 16, 9:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +436.5% upside

Low Target $7.67

Average Target $12.93

High Target $16.62

Current Price $2.41

Current
$2.41

Target
$12.93

$7.67 $12.93 avg $16.62

Scenario Analysis

Bear Case

$7.67

218.3%

Low target

Base Case

$12.93

+436.5%

Avg target

Bull Case

$16.62

+589.6%

High target

Risk/Reward

2.7x

Favorable

Price in Context

52-Week High

$4.53

-46.8% from high

52-Week Low

$1.65

+46.1% from low

Target vs 52W High

$12.93

+185.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%